Fig. 4From: Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021FDA-approved therapeutic drugs for gynecologic cancers. a Distribution of therapeutic drugs for gynecologic cancers during the past 31Â years (adapted from [864]). b Microtubule inhibitor. c PARP inhibitors. d PD1-directed mAb. e TF-targeted ADCBack to article page